Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Backlund, Lars
Skånér, Ylva
Montgomery, Henry
Bring, Johan
and
Strender, Lars-Erik
2004.
GPs' decisions on drug treatment for patients with high cholesterol values: A think-aloud study.
BMC Medical Informatics and Decision Making,
Vol. 4,
Issue. 1,
Backlund, Lars
Skånér, Ylva
Montgomery, Henry
Bring, Johan
and
Strender, Lars-Erik
2004.
The role of guidelines and the patient's life-style in GPs' management of hypercholesterolaemia.
BMC Family Practice,
Vol. 5,
Issue. 1,
Erhardt, Leif R.
2005.
Managing cardiovascular risk: reality vs. perception.
European Heart Journal Supplements,
Vol. 7,
Issue. suppl_L,
p.
L11.
Erhardt, Leif R.
and
Gotto, A.
2006.
The evolution of European guidelines: Changing the management of cholesterol levels.
Atherosclerosis,
Vol. 185,
Issue. 1,
p.
12.
Barrios, Vivencio
Escobar, Carlos
Calderón, Alberto
Luis Llisterri, José
Alegría, Eduardo
Muñiz, Javier
and
Matalí, Arantxa
2007.
Adecuación del tratamiento de los pacientes hipertensos con síndrome metabólico.
Medicina Clínica,
Vol. 128,
Issue. 17,
p.
647.
Barrios, V
Escobar, C
Calderón, A
Echarri, R
González-Pedel, V
and
Ruilope, L M
2007.
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
Journal of Human Hypertension,
Vol. 21,
Issue. 6,
p.
479.
Barrios, Vivencio
Escobar, Carlos
Calderón, Alberto
Llisterri, José L.
Echarri, Rocio
Alegría, Eduardo
Muñiz, Javier
and
Matalí, Arantxa
2007.
Blood Pressure and Lipid Goal Attainment in the Hypertensive Population in the Primary Care Setting in Spain.
The Journal of Clinical Hypertension,
Vol. 9,
Issue. 5,
p.
324.
Barrios, Vivencio
Escobar, Carlos
Calderón, Alberto
Llisterri, José L.
Alegría, Eduardo
Muñiz, Javier
and
Matalí, Arantxa
2007.
Prevalence of the Metabolic Syndrome in Patients With Hypertension Treated in General Practice in Spain: An Assessment of Blood Pressure and Low‐Density Lipoprotein Cholesterol Control and Accuracy of Diagnosis.
Journal of the CardioMetabolic Syndrome,
Vol. 2,
Issue. 1,
p.
9.
Laforest, Laurent
Moulin, Philippe
Schwalm, Marie-Sophie
Le Jeunne, Philippe
Chretin, Stephanie
Kitio, Brice
Massol, Jacques
and
Van Ganse, Eric
2007.
Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs.
Nutrition, Metabolism and Cardiovascular Diseases,
Vol. 17,
Issue. 9,
p.
657.
Escobar, C.
Barrios, V.
Calderón, A.
Llisterri, J.L.
García, S.
Rodríguez-Roca, G.C.
and
Matalí, A.
2007.
Diabetes mellitus en la población hipertensa asistida en Atención Primaria en España. Grado de control tensional y lipídico.
Revista Clínica Española,
Vol. 207,
Issue. 5,
p.
221.
Volpe, M.
and
Tocci, G.
2008.
Managing hypertension in cardiology practice according to risk profile.
International Journal of Clinical Practice,
Vol. 62,
Issue. 9,
p.
1403.
Volpe, Massimo
Erhardt, Leif R W
and
Williams, Bryan
2008.
Cardiovascular Risk Management in Clinical Practice.
High Blood Pressure & Cardiovascular Prevention,
Vol. 15,
Issue. 1,
p.
9.
Bakris, George
Böhm, Michael
Dagenais, Gilles
Diener, Hans-Christoph
Fujita, Toshiro
Gorelick, Philip
Kjeldsen, Sverre Erik
Laakso, Markku
Mancia, Giuseppe
Pitt, Bertram
Sharma, Arya
Sleight, Peter
Teo, Koon
Unger, Thomas
Weber, Michael
Williams, Bryan
and
Zannad, Faiez
2008.
Cardiovascular protection for all individuals at high risk: evidence-based best practice.
Clinical Research in Cardiology,
Vol. 97,
Issue. 10,
p.
713.
Vancheri, Federico
Strender, Lars-Erik
Bring, Johan
Montgomery, Henry
Skånér, Ylva
and
Backlund, Lars G.
2008.
General practitioners’ coronary risk assessments and lipid-lowering treatment decisions in primary prevention: comparison between two European areas with different cardiovascular risk levels.
Primary Health Care Research & Development,
Vol. 9,
Issue. 04,
p.
248.
Erhardt, Leif R.
Leiter, Lawrence A.
and
Richard Hobbs, F.D.
2008.
Lipid management in cardiovascular disease prevention guidelines: Strategies and tactics for implementation.
Atherosclerosis,
Vol. 196,
Issue. 2,
p.
532.
Vancheri, Federico
Strender, Lars-Erik
Montgomery, Henry
Skånér, Ylva
and
Backlund, Lars G.
2009.
Coronary risk estimates and decisions on lipid-lowering treatment in primary prevention.
European Journal of Internal Medicine,
Vol. 20,
Issue. 6,
p.
601.
Urdea, Mickey
Kolberg, Janice
Wilber, Judith
Gerwien, Robert
Moler, Edward
Rowe, Michael
Jorgensen, Paul
Hansen, Torben
Pedersen, Oluf
Jørgensen, Torben
and
Borch-Johnsen, Knut
2009.
Validation of a Multimarker Model for Assessing Risk of Type 2 Diabetes from a Five-Year Prospective Study of 6784 Danish People (Inter99).
Journal of Diabetes Science and Technology,
Vol. 3,
Issue. 4,
p.
748.
Alonso-Cerezo, María Concepción
Martín, José Simón
García Montes, Miguel Angel
and
de la Iglesia, Verónica Marcos
2009.
Appropriate utilization of clinical laboratory tests.
Clinical Chemistry and Laboratory Medicine,
Vol. 47,
Issue. 12,
Peracino, A.
and
Paoletti, R.
2009.
The Lorenzini Foundation in a changing scenario of patient management.
Atherosclerosis Supplements,
Vol. 10,
Issue. 1,
p.
22.
Atella, V.
Brady, A.
Catapano, A.L.
Critchley, J.
Graham, I.M.
Hobbs, F.D.R.
Leal, J.
Lindgren, P.
Vanuzzo, D.
Volpe, M.
Wood, D.
and
Paoletti, R.
2009.
Bridging science and health policy in cardiovascular disease: focus on lipid management.
Atherosclerosis Supplements,
Vol. 10,
Issue. 1,
p.
3.